Buspirone for the treatment of nausea and vomiting
A technology of buspirone, an emetic, used in the treatment of nausea and vomiting, which can solve the problem of increased risk
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment Construction
[0010] Buspirone may be in the form of a salt, hydrate or solvate. Salts include pharmaceutically acceptable salts, such as acid addition salts derived from inorganic or organic acids, such as hydrochloride, hydrobromide, p-toluenesulfonate, phosphate, sulfate, perchlorate, acetate, Tribromoacetate, propionate, citrate, malonate, succinate, lactate, oxalate, tartrate and benzoate.
[0011] Salts with bases are also possible. Such salts include those derived from inorganic or organic bases, such as alkali metal salts such as magnesium or calcium salts, and organic amine salts such as morpholine, piperidine, dimethylamine or diethylamine salts.
[0012] For the present invention, buspirone is preferably administered by intravenous, transdermal or rectal route. In addition, subcutaneous, inhalational, sublingual, buccal, and nasal routes may be employed, wherein (where appropriate) access of the parent drug to the stomach is limited.
[0013] The pharmaceutical composition con...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com